Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MetaCure Inc.

Latest From MetaCure Inc.

Market Intel: Intragastric Balloons And Other Innovations To Inflate Weight Loss Devices Market

The global market for minimally invasive weight loss devices is expected to grow to $290m by 2021, a CAGR of 16%, driven in large part by the rising obesity epidemic and associated Type 2 diabetes. Meddevicetracker expects that enhancements and innovations, particularly in the growing intragastric balloon market, and emerging technologies by smaller companies, will lead the growth in the overall weight loss devices market. In this feature, we'll take a closer look at the overall market and regional landscape and take a deep dive into the fastest-growing intragastric balloon segment, providing key insights from a bariatric surgeon on the pros and cons of these technologies.

Analysis Commercial

Obesity 2015: Less Invasive Options Will Drive Growth In Market Hungry For Solutions

Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.

Medical Device Innovation

ASMBS Highlights New Developments in Bariatric Surgery

A record-breaking attendance at 2010's meeting of the American Society for Metabolic and Bariatric Surgery marked the growing interest in new ways to address the issue of obesity. Currently, less than 1% of a potential US patient population of 15 million who might benefit from bariatric surgery actually undergo the procedure, and surgeons are scrambling to understand why and to identify new, less invasive approaches that might help them better penetrate this enormous patient pool.

Medical Device

Beta-Stim Ltd.

A new implantable device from Beta-Stim Ltd. is designed to eradicate type 2 diabetes. The start-up's Balance System provides electrical stimulation of the duodenum during food intake to reduce blood glucose levels. This profile was originally published in the June 2010 issue of Medtech Insight.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MetaCure Inc.
  • Senior Management
  • Shai Policker, VP, Bus. Dev.
  • Contact Info
  • MetaCure Inc.
    Phone: (845) 359-2143
    30 Ramland Rd. South
    P.O. Box 2044 Orangeburg, NY 10962